tirzepatide injection vs tablets injections Tirzepatide vs. Semaglutide: Key Differences & Benefits Injecting Tirzepatide in Love Handles:

Clinical trials in the SURPASS program have demonstrated that tirzepatide effectively reduces hemoglobin A1C levels by approximately 1.6% to 2.4% on average, with effects varying by baseline A1C, dose, and individual response

[1] [3] Tirzepatide is not indicated for use in type 1 diabetes

Another concern with taking weight-loss drugs is overdosing

Preliminary evidence also suggests that tirzepatide may confer cardiovascular benefits by improving lipid metabolism (e.g., lowering LDL cholesterol) and reducing inflammation (e.g., lowering C-reactive protein)

DrMedHealth offers oral semaglutide ($199/mo) and oral tirzepatide ($299/mo) as sublingual dissolving tablets